baber/WOPTO huggingface dataset:
Patent NZ-580201-A (NZ)
Title: A protective device for protecting the hip area including an impact sensor and alarm
Inventor: O'CONNOR SEAN JAMES
IPC: A41D13/05
Filed: 2009-10-06
Abstract: Disclosed is a protective device (1) for protecting the hip area. The device includes: a guard formed from a rigid body; a securing portion (8); an impact sensor to determine when an impact has occurred; and a communication assembly. The securing portion positions the guard against a person's body to facilitate protecting the hip joint. The communication assembly alerts a monitoring service when the sensor detects that a fall has occurred.
Patent NZ-587548-A (NZ)
Title: Pharmaceutical uses of N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide
Inventor: HADIDA RUAH SARAH S
IPC: A61K31/47
Filed: 2005-06-24
Abstract: Disclosed is the use of N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for treating or lessening the severity of a disease in a patient, wherein said disease is selected from hereditary emphysema, hereditary hemochromatosis, coagulation-fibrinolysis deficiencies, lipid processing deficiencies, lysosomal storage diseases, polyglutamine neurological disorders, and spongiform encephalopathies, and specifically wherein the disease is COPD, dry-eye disease, or emphysema. Also disclosed is the use of N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for treating or lessening the severity of cystic fibrosis, wherein the patient possesses a class III, class IV, or class V CFTR mutation, wherein said mutation is not a DF508 CFTR mutation or a G551D CFTR mutation.
Patent NZ-588862-A (NZ)
Title: Cellulosic and lignocellulosic structural materials and methods and systems for manufacturing such materials by irradiation
Inventor: MEDOFF MARSHALL
IPC: C12P7/06
Filed: 2009-04-28
Abstract: Disclosed is a method comprising: quenching a biomass feedstock that has been irradiated with electron beam radiation to ionize the biomass feedstock so that the biomass feedstock has a first level of radicals, without dissolving the feedstock, to an extent that the quenched biomass feedstock has a second level of radicals lower than the first level, by contacting the biomass with a gas capable of reacting with the radicals, wherein the biomass feedstock comprises a cellulosic or lignocellulosic material. Also disclosed is a biomass feedstock processing system when used for performing the method comprising: an irradiating device configured to ionize a biomass feedstock so that the feedstock has a first level of radicals detectable with an electron spin resonance spectrometer; and a quenching device configured to quench the ionized biomass feedstock to an extent that the radicals are at a second level lower than the first level.
Patent NZ-590160-A (NZ)
Title: AKT protein kinase inhibitors
Inventor: MITCHELL IAN S
IPC: C07D401/00
Filed: 2004-11-19
Abstract: Disclosed are serine/threonine protein kinases (e.g., AKT and related kinases) of formula I, wherein the substituents are as described within the specification. An example of a compound of formula I includes (2R)-2-amino-3-phenyl-1-(4-quinazolin-4-yl-piperazin-1-yl)-propan-1-one. Further disclosed is a composition comprising a compound of formula I and a pharmaceutically acceptable carrier. Also disclosed is the use of a compound of formula I in the manufacture of a medicament for the treatment of a hyperproliferative disorder or an inflammatory condition.
Patent NZ-593933-A (NZ)
Title: Damping device
Inventor: LINKA MARTIN
IPC: F16B5/02
Filed: 2009-12-02
Abstract: 593933 Disclosed is a vibration damping device for bolt or threaded fasteners or anchors. The device has a feed-through opening for an anchor, the damping device includes an elastomeric sleeve which in the installed state encircles the anchor. The elastomeric sleeve is clamped axially with the anchor, the elastomeric sleeve is compressed, so that it is without mechanical movement both at its inner periphery and at its outer periphery. The damping device further includes an adapter sleeve in which the elastomeric sleeve is accommodated in the installed state. The elastomeric sleeve has an apertured disc at an end face and includes a hollow cone in which the elastomeric sleeve is accommodated in the installed state and in which it is located without mechanical movement when it is axially clamped. The hollow cone tapers in the direction in which the elastomeric sleeve is introduced and has a bevel for coaxial alignment during introduction into a hole. A plastically deformable element is arranged to be fixed in place on the anchor in the radial direction in the installed state.
Patent NZ-603213-A (NZ)
Title: Method, system and apparatus for tracking and monitoring moving objects
Inventor: JUSTICE MARK
IPC: G01S17/06
Filed: 2011-03-24
Abstract: Disclosed is a method of tracking at least one moving object (4) traversing a predefined course. Line-of-sight EM- radiation (3) is emitted from at least one beacon (2), located to provide a means of reference for the at least one moving object. At least one image is captured including a representation of the transmitted EM radiation (3) by digital image recording at one or more of a plurality of predetermined locations relative to the predefined course. Position information is extracted regarding the at least one transmitting beacon (2) from the at least one captured image relative to each frame of the captured image. Each extracted position is then referenced with predetermined survey data of the predefined course to produce referenced position data from which a model of the path traversed by the at least one moving object (4) on the predefined course is generated.
Patent NZ-609201-A (NZ)
Title: Means and methods for treating dlbcl
Inventor: ZUGMAIER GERHARD
IPC: C07K16/46
Filed: 2011-10-27
Abstract: Disclosed is a use of a CD19xCD3 bispecific antibody for the preparation of a pharmaceutical composition for the treatment of tumorous mass of lymph node tissue and/or extranodal lymphoma caused by diffuse large B cell lymphoma (DLBCL) in a patient, wherein the pharmaceutical composition is to be administered in combination with at least one glucocorticoid.
Patent NZ-610464-A (NZ)
Title: Antigen binding proteins to oncostatin m (osm)
Inventor: BEMBRIDGE GARY PETER
IPC: C07K16/24
Filed: 2011-11-21
Abstract: Disclosed is an antigen binding protein which specifically binds to Oncostatin M (OSM) and which inhibits the binding of OSM to the gp130 receptor but does not directly interact with site II residues and wherein the antigen binding protein comprises the CDRs of the sequences as defined in the specification. Also disclosed is the use of the antigen binding protein in the manufacture of a medicament for treating a human patient afflicted with an inflammatory disorder or disease.
Patent NZ-616061-A (NZ)
Title: Recycling toxic gases
Inventor: DEAR LANCE ALLEN
IPC: B01J38/02
Filed: 2012-10-01
Abstract: 616061 Disclosed herein is a method of obtaining fumigant for re-use or disposal, comprising the steps of passing a gaseous flow comprising used fumigant such as methyl bromide through a container which contains fumigant absorbent, such as activated carbon; heating the absorbent so that it releases at least some of the absorbed fumigant to a gaseous flow; capturing the released fumigant by cooling to -5°C to 25°C and to have a pressure of 1 bar to 15 bar; and subsequently at a temperature of -5°C to -45°C and to have a pressure of 15 to 45 bar. Additionally disclosed is an apparatus for obtaining fumigant for re-use.
Patent NZ-616745-A (NZ)
Title: Antisense formulation
Inventor: KRILLA NICOLE D
IPC: A61K31/713
Filed: 2009-07-13
Abstract: Disclosed is a liquid formulation comprising: a)an oligonucleotide comprising SEQ ID NO: 1 or comprising a variant oligonucleotide in which no more than 3 non-sequential bases are different from SEQ ID NO: 1; and b)an aqueous carrier comprising an aggregation-preventing compound selected from the group consisting of mono and disaccharides and/or sugar alcohols, wherein the oligonucleotide is present at a concentration of at least 25 mg/ml, and wherein the sequence is as defined in the complete specification.
Patent NZ-625066-A (NZ)
Title: Metalloporphyrin neurological treatments
Inventor: PATEL MANISHA
IPC: A61P25/28
Filed: 2012-12-03
Abstract: Disclosed herein is the use of metalloporphyrin compounds of formulae I-XVII for treating a subject suffering from exposure to a chemical threat agent.
Patent NZ-626984-A (NZ)
Title: Method of forming bonding structure
Inventor: YAMAZAKI FUJIO
IPC: E04C5/18
Filed: 2012-12-21
Abstract: Disclosed is a method for forming a compression-bonded structure using the reinforcing bar and the compression-bonding fixture. The compression-bonded structure comprises a compression-bonding fixture (1) which is compression-bonded to a reinforcing bar (2). The compression-bonded fixture comprises a through-hole into which the reinforcing bar (2) is inserted, wherein a coating liquid (11) admixed with a granular fine powder (10) is applied in advance to the reinforcing bar (2) and/or the interior of the penetrating hole of the compression-bonding fixture (1), and the compression-bonding fixture (1) is compression-bonded to the reinforcing bar (2), which has been passed through the penetrating hole. The granular fine powder, which increases the friction resisting the force pulling the inserted reinforcing bar out of the penetrating hole, is thereby disposed between the abutting faces of the compression-bonding fixture (1) and the reinforcing bar (2) inserted into the penetrating hole of the compression-bonding fixture. The granular fine powder has a grain size between 180 um and 600 um and may be formed predominantly of silicon carbide or aluminium.
Patent NZ-629966-A (NZ)
Title: Working platform system
Inventor: SHANE MICHAEL MORWOOD
IPC: E04G3/28
Filed: 2014-09-02
Abstract: A system for the installation of an insulation material, comprises a platform that is able to be temporarily located at a selected storey of a multi-storey building. The system is operable such that, once the platform has been located at the selected storey of the building, it is able to be employed to install the insulation material at the selected storey of the building.
Patent NZ-704718-A (NZ)
Title: Epcam aptamer for detection of cancer stem cells
Inventor: DUAN WEI
IPC: C12N15/115
Filed: 2013-08-02
Abstract: The present disclosure relates to an RNA aptamer and uses thereof, in particular, an aptamer which specifically bind to EpCAM and which demonstrates superior tumor penetrating ability.
Patent NZ-709512-A (NZ)
Title: Process for producing a coated packaging material and packaging material having at least one barrier layer for hydrophobic compounds
Inventor: ZISCHKA MICHAEL
IPC: C09D129/04
Filed: 2013-12-06
Abstract: The invention relates to a method for producing a coated packaging material (10), in which at least the steps of a) providing a substrate (12) having a base material (14) of cellulose, an outer side (16) to be faced away from the packaging item as well as an inner side (18) to be faced towards the packaging item, b) coating at least the inner side (18) of the substrate with a layer system (20) comprising at least one layer of an aqueous composition, which includes at least polyvinyl alcohol and/or at least one polyvinyl alcohol copolymer as well as a cross-linking agent, wherein the aqueous composition has at most 40 % by wt. of polyvinyl alcohol and/or polyvinyl alcohol copolymer and a total solid content of at most 55 % by wt., and c) drying the layer and cross-linking the polyvinyl alcohol and/or the polyvinyl alcohol copolymer with the aid of the cross-linking agent with formation of a barrier layer (22a, 22b) for hydrophobic compounds are performed; and d) optionally including a cover layer (24) on barrier layer (22b) as shown, or alternatively including layer (24) between barrier layers (22a) and (22b). The invention furthermore relates to a packaging material (10) with at least one barrier layer (22a, 22b) for hydrophobic compounds.
Patent NZ-710740-A (NZ)
Title: Glycopyrrolate salts
Inventor: ANDRES PATRICIA
IPC: A61K31/40
Filed: 2014-02-28
Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.
Patent NZ-711753-A (NZ)
Title: Ectoparasite control agent
Inventor: IWASA TAKAO
IPC: C07D335/02
Filed: 2014-02-28
Abstract: In one embodiment, to provide a compound of formula (III) for use as an ectoparasite control agent. In formula (III), X1 represents an unsubstituted or substituted C1-6 alkyl group or the like; m1 represents an integer of 0-5; A represents an oxygen atom or a sulfur atom; each of R1 and R2 independently represents a hydrogen atom, an unsubstituted or substituted C1-6 alkyl group or the like; R5 represents a hydrogen atom or an unsubstituted or substituted C1-6 alkyl group; B represents an oxygen atom or a sulfur atom; Q2 represents an unsubstituted or X2-substituted C7-11 aralkyl group or the like; and each of R3a, R3b, R4a and R4b independently represents a hydrogen atom, an unsubstituted or substituted C1-6 alkyl group or the like.
Patent NZ-711807-A (NZ)
Title: Modified t lymphocytes having improved specificity
Inventor: ABBOT STEWART
IPC: C12N5/02
Filed: 2014-02-06
Abstract: Provided is a modified T lymphocyte (CAR-T lymphocyte) which allows for tumour cell specific cytotoxicity, comprising: a. a first polypeptide comprising a first extracellular antigen binding domain that binds a first antigen, and a first intracellular signaling domain that comprises an immunoreceptor tyrosine-based activation motif (ITAM), and wherein said first polypeptide does not comprise a co-stimulatory domain; and b. a second polypeptide comprising a second extracellular antigen binding domain binding a second antigen, or a receptor that binds said second antigen; and a second intracellular signaling domain that comprises one or more co-stimulatory domains but not an ITAM; or a. a first polypeptide comprising a first extracellular antigen binding domain that binds a first antigen, and a first intracellular signaling domain that comprises one or more co-stimulatory domains but not an immunoreceptor tyrosine-based activation motif (ITAM); and b. a second polypeptide comprising a second extracellular antigen binding domain binding a second antigen, or a receptor that binds said second antigen; and a second intracellular signaling domain, that comprises an ITAM, wherein said second polypeptide does not comprise a co-stimulatory domain; wherein: said first antigen is an antigen on a tumor cell, a tumor-associated antigen, or a tumor-specific antigen; the second antigen is vascular endothelial growth factor (VEGF) or a damage associated molecular pattern molecule (DAMP); and said modified lymphocyte becomes maximally cytotoxic only when said first signaling domain and said second signaling domain are both activated by said first antigen and said second antigen, respectively.
Patent NZ-713303-A (NZ)
Title: 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
Inventor: BOTELLA GABRIEL MARTINEZ
IPC: A61K31/58
Filed: 2014-04-17
Abstract: Provided herein are 19-nor C3,3-disubstituted C21-pyrazolyl steroids of Formula (SA-4), and pharmaceutically acceptable salts thereof. The compounds are contemplated useful for the prevention and treatment of a variety of CNS-related conditions, for example, treatment of sleep disorders, mood disorders, schizophrenia spectrum disorders, convulsive disorders, disorders of memory and/or cognition, movement disorders, personality disorders, autism spectrum disorders, pain, traumatic brain injury, vascular diseases, substance abuse disorders and/or withdrawal syndromes, and tinnitus.
Patent NZ-722254-A (NZ)
Title: Administration of tasimelteon under fasted conditions
Inventor: DRESSMAN MARLENE
IPC: A61K31/343
Filed: 2015-01-07
Abstract: One embodiment of the invention provides a method for administering tasimelteon to a human patient that comprises orally administering an effective dose of tasimelteon under fasted conditions. Fasted conditions may comprise administering the tasimelteon without food, no food at least 1/2 hour prior to administration, no food at least 1 hour prior to administration, no food at least 1-1/2 hours prior to administration, no food at least 2 hours prior to administration, no food at least 2-1/2 hours prior to administration, or no food at least 3 hours prior to administration. According to such embodiments, tasimelteon may be administered, for example, at a dose of 20 mg/d. Tasimelteon may be administered where, for example, the patient is being treated for a circadian rhythm disorder or for a sleep disorder, including, for example, Non-24 Disorder.
Patent NZ-760323-A (NZ)
Title: Mask system
Inventor: BARLOW ADAM
IPC: A61M16/00
Filed: 2011-08-31
Abstract: Disclosed is a CPAP breathing mask system with a headgear and cushion module and a seal and frame module that provide a better air-tight seal between the mask and the user’s face. The seal and frame module includes a sealing portion adapted to form a seal with a patient’s face and a frame portion adapted to form a breathing chamber. The headgear and cushion module includes a cushion region adapted to support and shape the sealing portion and a headgear region adapted to support and stabilize the mask system on the patient’s face. The headgear and cushion module includes a composite including an outer fabric layer that provides an exterior surface of the headgear and cushion module, the cushion region including a cushioning component within the composite. The sealing portion of the seal and frame module includes a first side and a second side opposite to the first side, the first side providing the sealing portion, and the second side providing a channel , wherein the channel is configured to receive the cushion region of the headgear and cushion module and to maintain the position of the cushion region on the patient’s face in use.
Patent NZ-765223-A (NZ)
Title: Use of cannabinoids in the treatment of epilepsy
Inventor: GUY GEOFFREY
IPC: A61K31/05
Filed: 2015-06-17
Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE). In particular, the disclosure relates to the use of CBD of treating TRE when the TRE is Dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (FIRES). The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
Patent NZ-774518-A (NZ)
Title: Humidification of respiratory gases
Inventor: VIRR ALEXANDER
IPC: A61M16/10
Filed: 2009-03-05
Abstract: A respiratory apparatus for delivering a humidified flow of breathable gas to a heated air delivery tube for delivery to a patient, the respiratory apparatus comprising: a humidifier configured to store a supply of water to humidify the flow of breathable gas, the humidifier comprising a humidifier heating element configured to heat the supply of water; and a controller configured to control the humidifier heating element based on detection of the presence and/or absence of the heated air delivery tube in connection with the humidifier.
Patent PT-101629-A (PT)
Title: Digital lock
IPC: E05B47/00
Filed: 1995-01-04
Abstract: The invention is a digital lock that combines mechanical and electromagnetic functions operated by code. The handle 8 is mounted on the square shaft 2 which forms part of the following gear system: when the armature 15, which has the fork 14 on the base, is attracted by the electromagnetization of the inductor 9 it will cause the cam 13 to slide on the square shaft 2 and raise it to engage in the box 11, enabling the functions of closing and opening. If the electrical power fails, the digital lock has an emergency button 18 which allows it to be manually opened from inside the house. Outside the house it will be sufficient to press a keyboard button to activate the power of an auxiliary battery and key in the code. The main use of this digital lock is in dwellings owing to its exceptional security conditions, since, not being key-operated, it does not have a barrel nor any slot or orifice through which any break-in object can be inserted. <IMAGE>
Patent PT-104826-A (PT)
Title: Transdutor indutivo para ensaios n?o-destrutivos em materiais condutores com capacidade de gera??o de campos magn?ticos de excita??o uniforme e de detec??o do campo magn?tico induzido utilizando magnetoresist?ncias de tipo gigante
Inventor: POSTOLACHE OCTAVIAN
IPC: G01N27/82
Filed: 2009-11-20
Abstract: Este invento, desenvolvido na ?rea da Engenharia Electrot?cnica, aplica-se ao ensaio n?o destrutivo de chapas de material condutor, na detec??o de defeitos no material como fissuras de fadiga mec?nica ou defeitos nas linhas de soldadura. Trata-se de um transdutor indutivo com uma bobina de excita??o de sec??o rectangular (3), para a gera??o de campo magn?tico alternado espacialmente uniforme na zona da estrutura que est? a ser analisada e um sensor magnet?metro com magnetoresist?ncias gigantes (4) para detec??o do campo magn?tico secund?rio resultante das correntes de Foucault que se desenvolvem por indu??o na estrutura (8). Por deslocamento do transdutor sobre a estrutura a ensaiar (8) e utilizando um sistema de condicionamento, aquisi??o e processamento dos sinais e ap?s efectuar o processamento implementado no programa instalado, s?o extra?dos os valores da amplitude e da fase do campo secund?rio cujas varia??es indicam a exist?ncia de defeitos na estrutura mec?nica em ensaio.
Patent PT-108556-A (PT)
Title: Caixa anti-insectos
IPC: B65D81/28
Filed: 2015-06-16
Abstract: O PRESENTE INVENTO REFERE-SE A UMA CAIXA PARA GUARDAR E PROTEGER ALIMENTOS, CUJA FINALIDADE É IMPEDIR O CONTACTO ENTRE INSETOS RASTEJANTES, TREPADORES E VOADORES E OS ALIMENTOS, A COMIDA, E OUTROS PRODUTOS COMESTÍVEIS. ESTA CAIXA É CONSTITUÍDA POR PAREDES EXTERIORES (1) E POR PAREDES INTERIORES (2), FIXAS PELA BASE (5) RESULTANDO DESTA ESTRUTURA, QUER UMA CÂMARA EXTERNA (4) PARA COLOCAR ÁGUA, OU OUTRO LÍQUIDO QUE CONSTITUA UM OBSTÁCULO AOS INSETOS RASTEJANTES E TREPADORES, QUER UMA CÂMARA INTERNA (3), PARA COLOCAR OS PRODUTOS COMESTÍVEIS. APENAS A CÂMARA INTERNA (3) É FECHADA COM TAMPA (8), A QUAL ENCAIXA NA ZONA DE ENCAIXE (7). NA CÂMARA INTERNA (3) EXISTEM SALIÊNCIAS TIPO GANCHOS (6) PARA INCORPORAR REDES TIPO MOSQUITEIRAS. O PRESENTE INVENTO É APLICÁVEL EM CONTEXTO DOMÉSTICO, NA INDÚSTRIA ALIMENTAR, RESTAURAÇÃO, LAZER, E TODAS AS ÁREAS E INDÚSTRIAS EM QUE A GUARDA E PROTEÇÃO DE PRODUTOS COMESTÍVEIS SEJAM NECESSÁRIAS.
Patent PT-110223-A (PT)
Title: Sistema de assinatura de voz indiscutível e não repudiável, legalmente vinculante
Inventor: RICARDO NUNO CRAVEIRO LOPES
IPC: G06F21/64
Filed: 2017-07-27
Abstract: A PRESENTE INVENÇÃO COMPREENDE UM NOVO SISTEMA QUE PERMITE QUE ALGUÉM ASSINE UM DOCUMENTO, INCLUINDO REMOTAMENTE, VIA GSM OU UM APLICATIVO WEB / MÓVEL, USANDO APENAS SUA VOZ E SEU CELULAR TELEMÓVEL (SEJA OU NÃO UM SMARTPHONE), QUALQUER DISPOSITIVO DE COMPUTADOR MÓVEL QUE INCLUA UM MICROFONE OU COMPUTADOR DE MESA TAMBÉM COM UM MICROFONE. A NOVIDADE NESTE SISTEMA É QUE ELE É O PRIMEIRO A AGREGAR UM CONJUNTO COMPLETO DE RECURSOS QUE, PELA PRIMEIRA VEZ, ASSEGURA QUE, POR UM LADO, ELE NÃO PRECISA DE UMA INFRAESTRUTURA DE CHAVE PÚBLICA (PKI) NEM A EMISSÃO DE CHAVES PRIVADAS / PÚBLICAS PARA CADA SIGNATÁRIO, ENQUANTO QUE, POR OUTRO LADO, ELE PERMITE ASSINAR ELETRONICAMENTE UM DOCUMENTO DE MANEIRA VERDADEIRA, INDISCUTÍVEL E NÃO REPUDIÁVEL, COM SEGURANÇA E CONVENIÊNCIA SUPERIORES ÀQUELAS DAS ATUAIS TECNOLOGIAS DE ASSINATURA DIGITAL DISPONÍVEIS, COM A FACILIDADE COMPARÁVEL A UMA ASSINATURA MANUSCRITA TRADICIONAL NUM DOCUMENTO EM PAPEL.